Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allarity Therapeutics (ALLR) Shares Outstanding (Weighted Average) (2024 - 2025)

Allarity Therapeutics' Shares Outstanding (Weighted Average) history spans 2 years, with the latest figure at $14.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 794.78% year-over-year to $14.4 million; the TTM value through Dec 2025 reached $14.4 million, up 794.78%, while the annual FY2025 figure was $14.4 million, 794.78% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $14.4 million in Q4 2025 per ALLR's latest filing, up from $13.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $15.5 million in Q2 2025 to a low of $5842.0 in Q1 2024.